ASTRAZEN2 months ago
Astrazeneca Pharma India Limited (astrazen) Q1 Fy2026-27: Revenue Surges 30% to INR 6,828 Mn
AstraZeneca Pharma India Limited (ASTRAZEN) reports 30% revenue growth in Q1 FY2026-27, reaching INR 6,828 Mn, driven by strong portfolio and strategic partn.